PYRAMID and LYM2034: Targeted randomized phase II studies of bortezomib with or without immunochemotherapy in newly diagnosed nongerminal center B-cell-like (GCB) diffuse large B-cell lymphoma (DLBCL), including rapid prospective non-GCB subtype identification.
dc.contributor.author | Flinn, I. W. | |
dc.contributor.author | Leonard, J. | |
dc.contributor.author | Reeves, J. | |
dc.contributor.author | Ferhanoglu, B. | |
dc.contributor.author | Doner, K. T. | |
dc.contributor.author | Eom, H. | |
dc.contributor.author | Raposo, J. | |
dc.contributor.author | Chowhan, N. M. | |
dc.contributor.author | Suh, C. | |
dc.contributor.author | Noga, S. | |
dc.contributor.author | Tumyan, G. | |
dc.contributor.author | Aung, S. | |
dc.contributor.author | Hajdenberg, J. | |
dc.contributor.author | Ulrich, B. K. | |
dc.contributor.author | Pendergrass, K. B. | |
dc.contributor.author | Mulligan, G. | |
dc.contributor.author | Rizo, A. | |
dc.contributor.author | Kussick, S. | |
dc.contributor.author | Offner, F. | |
dc.date.accessioned | 2021-03-05T21:12:23Z | |
dc.date.available | 2021-03-05T21:12:23Z | |
dc.date.issued | 2011 | |
dc.identifier.citation | Leonard J., Reeves J., Ferhanoglu B., Doner K. T. , Eom H., Flinn I. W. , Raposo J., Chowhan N. M. , Suh C., Noga S., et al., "PYRAMID and LYM2034: Targeted randomized phase II studies of bortezomib with or without immunochemotherapy in newly diagnosed nongerminal center B-cell-like (GCB) diffuse large B-cell lymphoma (DLBCL), including rapid prospective non-GCB subtype identification.", JOURNAL OF CLINICAL ONCOLOGY, cilt.29, 2011 | |
dc.identifier.issn | 0732-183X | |
dc.identifier.other | av_d7ca30b0-8e40-40a9-97c1-68b0556fcb9d | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/142378 | |
dc.identifier.uri | https://doi.org/10.1200/jco.2011.29.15_suppl.tps226 | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Onkoloji | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | İç Hastalıkları | |
dc.subject | Dahili Tıp Bilimleri | |
dc.title | PYRAMID and LYM2034: Targeted randomized phase II studies of bortezomib with or without immunochemotherapy in newly diagnosed nongerminal center B-cell-like (GCB) diffuse large B-cell lymphoma (DLBCL), including rapid prospective non-GCB subtype identification. | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF CLINICAL ONCOLOGY | |
dc.contributor.department | , , | |
dc.identifier.volume | 29 | |
dc.identifier.issue | 15 | |
dc.contributor.firstauthorID | 200522 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Makale [92796]